Product
mRNA-1273.211
2 clinical trials
1 indication
Indication
COVID-19Clinical trial
A Phase 2/3 Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 VariantsStatus: Completed, Estimated PCD: 2023-11-17
Clinical trial
A Phase 1/2 Study of Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA VaccinesStatus: Completed, Estimated PCD: 2023-06-16